ASENT's goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.
ASENT's 18th ANNUAL MEETING
Program Highlights include:
Neurotherapeutics® Journal Announcement
We are pleased to announce the new Neurotherapeutics® Impact Factor – 5.904. This Impact Factor places the journal 14th in Thomson Reuters’ Pharmacology & Pharmacy category (out of 260 journals), 11th in the Clinical Neurology category (out of 191 journals), and 30th in the Neurosciences category (out of 251 journals). Read more
Neurotherapeutics® is the official journal of ASENT published by Springer.